# Biodistribution, Pharmacokinetics, and Safety of F-18 THK-5351 PET in Alzheimer's Disease Patients and Healthy Subjects.(Positron Emission Tomograph )

> **NCT02686216** · PHASE1 · COMPLETED · sponsor: **Chang Gung Memorial Hospital** · enrollment: 24 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** F-18 THK-5351

## Key facts

- **NCT ID:** NCT02686216
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2016-04
- **Final completion:** 2016-11
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2021-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02686216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02686216, "Biodistribution, Pharmacokinetics, and Safety of F-18 THK-5351 PET in Alzheimer's Disease Patients and Healthy Subjects.(Positron Emission Tomograph )". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02686216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*